[Ip-health] Infojustice Roundup – November 2, 2015

Michael Palmedo mpalmedo at wcl.american.edu
Mon Nov 2 12:57:59 PST 2015

Infojustice Roundup


High-Level Negotiations On LDC Pharma IP Waiver Extension At WTO

[Catherine Saez] Negotiations have been ongoing at the World Trade Organization over the extension of a waiver allowing least-developed countries not to grant or enforce intellectual property rights on pharmaceutical products. The issue was unsuccessfully debated at the last meeting of the World Trade Organization intellectual property committee earlier this month. Since then, discussions have been ongoing between the Least Developed Countries (LDCs) Group and the United States, apparently the last WTO member to resist the LDCs’ request. The discussions on the issue have reached ambassador level. Click here for the full story on IP Watch.<http://www.ip-watch.org/2015/10/30/high-level-negotiations-on-ldc-ip-waiver-extension-at-wto/>


Stalled Policy Will Cost Lives: Patient Groups Appeal to Minister Davies

[Treatment Access Campaign] The Fix the Patent Laws (FTPL) Campaign, today called on the Department of Trade and Industry (DTI) to end years of pharmaceutical company price gouging and broken promises for patent law reform and produce a final intellectual property (IP) policy and bill to amend the Patents Act. The coalition released a detailed timeline revealing how broken promises by the DTI, and push back by the pharmaceutical industry have contributed to government’s delays in finalising reform of South Africa’s patent laws. Click here for more.<http://infojustice.org/archives/35252>


Does Compulsory Licensing Discourage Invention? Evidence from German Patents after World War I

[Joerg Baten, Nicola Bianchi, and Petra Moser] Abstract: This paper investigates whether compulsory licensing – which allows governments to license patents without the consent of patent-owners – discourages invention. Our analysis exploits new historical data on German patents to examine the effects of compulsory licensing under the US Trading-with-the-Enemy Act on invention in Germany. We find that compulsory licensing was associated with a 28 percent increase in invention. Click here for more.<http://infojustice.org/archives/35238>

More information about the Ip-health mailing list